Literature DB >> 30300913

Sensitivity and Specificity of a Weight Distribution Platform for the Detection of Objective Lameness and Orthopaedic Disease.

William T Clough1, Sherman O Canapp1, Luis De Taboada2, David L Dycus1, Christopher S Leasure1.   

Abstract

INTRODUCTION: Weight distribution and off-loading at the stance are commonly used subjective assessments during the orthopaedic examination. The clinical relevance, sensitivity and specificity of limb off-loading have not yet been established. The aim of the study was to assess off-loading on a weight distribution platform (WDP) and determine the sensitivity and specificity at various cut-off points for the detection of objective lameness (OL) and orthopaedic disease (OD).
MATERIALS AND METHODS: The total pressure index was used to determine OL on a pressure-sensitive walkway (PSW). Normal weight distribution on both the PSW and WDP was considered 30/30/20/20. A total pressure index standard deviation of 2 was used. The sensitivity and specificity of the WDP for the identification of OL and OD was determined at cut-off points 1 to 6 below normal weight distribution values.
RESULTS: All patients in the study (n = 50) had confirmed OD. The PSW identified 36/50 (74%) patients as OL; these were deemed to be OL for sensitivity and specificity analysis of WDP data. At cut-off point 1, the WDP had the highest sensitivity for OD (84%) and OL (97%). At cut-off point 6, the WDP had the highest specificity for OD (98%) and OL (98%). The highest combination of sensitivity and specificity for both OD (1.65) and OL (1.80) was at cut-off point 2. DISCUSSION/
CONCLUSION: The WDP provided the highest combined sensitivity and specificity at cut-off point 2 below the normal value for the detection of both OL and OD. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30300913     DOI: 10.1055/s-0038-1667063

Source DB:  PubMed          Journal:  Vet Comp Orthop Traumatol        ISSN: 0932-0814            Impact factor:   1.358


  7 in total

1.  Stance and weight distribution after tibial plateau leveling osteotomy in fore limb and hind limb amputee dogs.

Authors:  Ron Ben-Amotz; David Dycus; David Levine; Andréia Gonçalves Arruda; Nicholas Fagan; Denis Marcellin-Little
Journal:  BMC Vet Res       Date:  2020-06-10       Impact factor: 2.741

2.  Clinical and diagnostic imaging findings in police working dogs referred for hip osteoarthritis.

Authors:  J C Alves; A Santos; P Jorge; C Lavrador; L Miguel Carreira
Journal:  BMC Vet Res       Date:  2020-11-07       Impact factor: 2.741

3.  Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model.

Authors:  J C Alves; A Santos; P Jorge; C Lavrador; L Miguel Carreira
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

4.  The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model.

Authors:  João C Alves; Ana Santos; Patrícia Jorge; Catarina Lavrador; L Miguel Carreira
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.752

5.  Comparison of clinical and radiographic signs of hip osteoarthritis in contralateral hip joints of fifty working dogs.

Authors:  J C Alves; Ana Santos; Patrícia Jorge; Catarina Lavrador; L Miguel Carreira
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.752

6.  Effect of a single intra-articular administration of stanozolol in a naturally occurring canine osteoarthritis model: a randomised trial.

Authors:  J C Alves; A Santos; P Jorge; C Lavrador; L Miguel Carreira
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

7.  Evaluation of digital thermography imaging to assess and monitor treatment of police working dogs with naturally occurring hip osteoarthritis.

Authors:  J C Alves; A Santos; P Jorge; C Lavrador; L Miguel Carreira
Journal:  BMC Vet Res       Date:  2021-05-01       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.